Searched for
INDIAN STROKE CLINICAL TRIAL NETWORK
Chinese-linked hackers targeted US, Canadian research facilities for a year: GoogleA Chinese-linked hacking group secretly stole data from U.S. and Canadian academic, medical, and military research institutions. The cybere...- RVNL, Railtel Corp, Titagarh Rail, other railway stocks rally up to 4% on Rs 16 lakh crore bullet train planRailway stocks including RVNL, Railtel and Titagarh Rail rose up to 4% after the government unveiled a Rs 16 lakh crore plan to develop sev...
- Business lesson from world's first trillionaire Elon Musk: 'Rely less on business gurus and their books and more on biographies' What business owners can learn from world's richest man's success mindsetElon Musk, the world's first trillionaire, eschews traditional business gurus, drawing wisdom from history and biographies of innovators. H...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- From rockets to brain implants, here's a look at Elon Musk's vast empireElon Musk, the world's richest man, leads a sprawling business empire. His ventures include electric vehicles, brain implants, underground ...
- Delhi to Siliguri in 6 hours? Railways have a Rs 16 lakh crore bullet train plan to connect major citiesIndia is embarking on a massive high-speed rail project. Seven dedicated corridors are planned, aiming to slash travel times between major ...
- DRDO's Netra Airborne Early Warning and Control aircraft to get final operational clearance on June 25Bengaluru will host the Final Operational Clearance ceremony for the Netra Airborne Early Warning and Control system on June 25. This marks...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Hexagon Nutrition shares list at 7% premium over IPO price on boursesHexagon Nutrition debuted at a premium of up to 7.2% over its IPO price, in line with grey market expectations. The Rs 138.9 crore issue wa...
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Paediatric healthcare startup Hoola Health raises $5 million from Peak XV’s Surge, othersThe Bengaluru-headquartered startup, founded in 2024 by Deeksha Senguttuvan, offers paediatric consultations, vaccinations, diagnostics, de...
- Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip raceElon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...
- In 1987, ophthalmologist Dr. Jean Carruthers noticed her crossed-eye patients' frown lines were vanishing, and Botox accidentally became cosmetic history's biggest hitOriginally developed to address eye disorders such as blepharospasm, Botox has evolved into a key player in the cosmetic industry since its...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- Indian men's hockey team beat Chinese Taipei 13-1 to enter semifinals of U-18 men's Asia CupThe Indian men's hockey team secured a dominant 13-1 victory over Chinese Taipei in their final Pool A match. This win propels India into t...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- KorinMi raises Rs 10 crore from Lotus Herbals to bring Korean skin treatment to IndiaFounded in 2024, KorinMi is a Korean beauty clinic that started with skin treatments and has now expanded to direct-to-consumer (D2C) produ...
- Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...
Load More
